News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
358,338 Results
Type
Article (32336)
Company Profile (97)
Press Release (325890)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (95309)
Career Advice (580)
Deals (12592)
Drug Delivery (81)
Drug Development (54582)
Employer Resources (51)
FDA (8919)
Job Trends (7821)
News (160609)
Policy (14000)
Tag
2027 BioCapital Standard (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2047)
Academic (1)
Accelerated approval (45)
ADA (23)
Adcomms (29)
Allergies (66)
Alliances (25277)
ALS (127)
Alzheimer's disease (1179)
Antibody-drug conjugate (ADC) (616)
Approvals (9219)
Artificial intelligence (490)
ASCO (335)
Autoimmune disease (230)
Automation (24)
Bankruptcy (115)
Belgium (3)
Best Places to Work (6566)
BIO (52)
Biologics (9)
BIOSECURE Act (4)
Biosimilars (144)
BioSpace Insights (60)
Biotechnology (80)
Bispecific (3)
Bladder cancer (230)
Brain cancer (91)
Breast cancer (915)
Cancer (7240)
Cardiovascular disease (260)
Career advice (488)
Career pathing (14)
CAR-T (347)
CDC (47)
CDMO (88)
Celiac Disease (2)
Cell therapy (793)
Cervical cancer (62)
Clinical research (48209)
Collaboration (1436)
Commercialization (3)
Company closure (6)
Compensation (515)
Complete response letters (54)
COVID-19 (1534)
CRISPR (68)
C-suite (689)
Cystic fibrosis (60)
Data (6309)
Decentralized trials (2)
Denatured (14)
Depression (64)
Dermatology (57)
Diabetes (316)
Diagnostics (4660)
Digital health (39)
Diversity (9)
Diversity, equity & inclusion (16)
Drug discovery (211)
Drug pricing (116)
Drug shortages (6)
Duchenne muscular dystrophy (89)
Earnings (30645)
Editorial (42)
Employer branding (7)
Employer resources (47)
Events (58013)
Executive appointments (555)
Eye disease (1)
FDA (11421)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (9)
Frontotemporal dementia (21)
Funding (1093)
Gene editing (124)
Generative AI (31)
Gene therapy (399)
GLP-1 (458)
Government (2576)
Grass and pollen (2)
Guidances (197)
Healthcare (11697)
Hematology (168)
HIV (56)
Huntington's disease (26)
IgA nephropathy (34)
Immunology and inflammation (166)
Immuno-oncology (132)
Indications (155)
Infectious disease (1737)
Inflammatory bowel disease (114)
Inflation Reduction Act (12)
Influenza (72)
Intellectual property (155)
Interviews (83)
IPO (6200)
IRA (38)
Job creations (1497)
Job search strategy (439)
JPM (33)
Kidney cancer (28)
Kidney disease (30)
Labor market (27)
Layoffs (275)
Leadership (10)
Legal (2203)
Licensing (18)
Liver cancer (114)
Longevity (19)
Lung cancer (1009)
Lymphoma (484)
Machine learning (40)
Management (17)
Manufacturing (597)
Marketing (4)
MASH (109)
Medical device (5730)
Medtech (5840)
Mergers & acquisitions (6938)
Metabolic disorders (747)
mRNA (187)
Multiple sclerosis (119)
NASH (5)
Neurodegenerative disease (220)
Neuropsychiatric disorders (50)
Neuroscience (1959)
NextGen: Class of 2026 (3657)
Non-profit (3190)
Now hiring (19)
Obesity (302)
Opinion (155)
Ovarian cancer (265)
Pain (148)
Pancreatic cancer (408)
Parkinson's disease (165)
Partnered (19)
Patents (341)
Patient recruitment (642)
Patient selection (6)
Peanut (18)
People (27361)
Peptides (3)
Pharmaceutical (16)
Pharmacy benefit managers (11)
Phase 1 (16032)
Phase 2 (21170)
Phase 3 (15316)
Pipeline (6868)
Policy (230)
Postmarket research (1642)
Preclinical (6509)
Press Release (33)
Prostate cancer (380)
Psychedelics (31)
Radioligand (1)
Radiopharmaceuticals (372)
Rare diseases (631)
Real estate (3363)
Recruiting (17)
Regenerative medicine (1)
Regulatory (13078)
Reports (22)
Research institute (1946)
Resumes & cover letters (82)
Rett syndrome (13)
RNA editing (10)
RSV (53)
Schizophrenia (89)
Series A (159)
Series B (116)
Service/supplier (2)
Sickle cell disease (74)
Special edition (9)
Spinal muscular atrophy (60)
Sponsored (22)
Startups (1733)
State (1)
Stomach cancer (22)
Substance use disorders (11)
Supply chain (60)
Tariffs (37)
The Weekly (63)
Vaccines (784)
Venture capital (60)
Weight loss (180)
Women's health (91)
Worklife (5)
Date
Today (28)
Last 7 days (272)
Last 30 days (1211)
Last 365 days (15979)
2026 (11545)
2025 (15952)
2024 (18648)
2023 (21230)
2022 (28517)
2021 (29672)
2020 (27642)
2019 (24246)
2018 (18105)
2017 (16317)
2016 (16007)
2015 (18337)
2014 (13720)
2013 (11191)
2012 (11694)
2011 (12106)
2010 (10974)
Location
Africa (305)
Alabama (30)
Alaska (4)
Arizona (179)
Arkansas (6)
Asia (23295)
Australia (3847)
California (7925)
Canada (1813)
China (1272)
Colorado (391)
Connecticut (339)
Delaware (295)
Europe (45983)
Florida (1192)
Georgia (257)
Hawaii (2)
Idaho (27)
Illinois (721)
India (67)
Indiana (388)
Iowa (16)
Japan (380)
Kansas (52)
Kentucky (35)
Louisiana (42)
Maine (14)
Maryland (943)
Massachusetts (5166)
Michigan (163)
Minnesota (378)
Mississippi (6)
Missouri (95)
Montana (18)
Nebraska (16)
Nevada (68)
New Hampshire (57)
New Jersey (2351)
New Mexico (19)
New York (2397)
North Carolina (705)
North Dakota (4)
Northern California (4192)
Ohio (236)
Oklahoma (14)
Oregon (21)
Pennsylvania (1498)
Puerto Rico (17)
Rhode Island (26)
South America (418)
South Carolina (38)
Southern California (3116)
Tennessee (162)
Texas (1715)
United States (28135)
Utah (187)
Vermont (2)
Virginia (148)
Washington D.C. (41)
Washington State (774)
West Virginia (3)
Wisconsin (109)
358,338 Results for "memorial sloan kettering cancer center".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay
March 10, 2026
·
6 min read
Press Releases
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026
April 3, 2026
·
4 min read
Press Releases
Scientists Turn COVID-19 Immune Memory into a Powerful New Ally Against Cancer
Nature Communications Publishes Breakthrough Study Showing How COVID-Era Immune Memory Can Be Redirected to Fight Cancer Celloram, Inc., University Hospitals, and Case Western Reserve University unveil PROTEXI, a novel cancer vaccine platform advancing toward first-in-human clinical trials in sarcoma patients.
July 27, 2026
·
1 min read
Press Releases
BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
September 8, 2026
·
4 min read
Press Releases
NYU Langone Health’s Perlmutter Cancer Center Appoints New Vice Chair of Physics and Dosimetry in the Department of Radiation Oncology
September 10, 2026
·
5 min read
Business
MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company’s Novel Oral Ketamine Analog
MIRA Pharmaceuticals, Inc. announced it is in advanced discussions with Memorial Sloan Kettering Cancer Center (MSK) to initiate a preclinical study evaluating MIRA’s novel oral ketamine analog, Ketamir-2, for the treatment of cancer-related pain and depression.
May 21, 2024
·
8 min read
Press Releases
Elicio Therapeutics Announces Investigator-Initiated Phase 1 Trial to be Conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation for Neoadjuvant ELI-002 7P in Pancreatic Ductal Adenocarcinoma
September 30, 2025
·
9 min read
Drug Development
Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer
IMUNON, Inc. (NASDAQ: IMNN) announces that Memorial Sloan Kettering Cancer Center has joined MD Anderson Cancer Center in enrolling patients in a Phase 1/2 clinical trial evaluating IMUNON’s IMNN-001 in combination with bevacizumab in patients with advanced ovarian cancer.
February 27, 2024
·
6 min read
Business
Nexcella Announces Dr. Heather Landau, Memorial Sloan Kettering Cancer Center Amyloidosis Program Director, Joins Nexcella Scientific Advisory Board
Dr. Landau joins the Nexcella Scientific Advisory Board with decades of hematology/oncology clinical trial experience at Memorial Sloan Kettering Cancer Center.
August 18, 2023
·
5 min read
Business
Immix Biopharma Announces Dr. Heather Landau, Memorial Sloan Kettering Cancer Center Amyloidosis Program Director, Joins Nexcella Scientific Advisory Board
Dr. Landau joins the Nexcella Scientific Advisory Board with decades of hematology/oncology clinical trial experience at Memorial Sloan Kettering Cancer Center.
August 18, 2023
·
6 min read
1 of 35,834
Next
